SCHEMBL8513816

SCHEMBL8513816

COc1cc2c(O)cc3c(c2cc1OC)-c1ccc(-c2ccccc2OC)cc1C3(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.47
PTPRC P08575 1/20 0.42
PTPN1 P18031 1/20 0.42
CHEK1 O14757 1/20 0.40
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
PGR P06401 2/20 0.38
NR3C1 P04150 1/20 0.38
PLG P00747 1/20 0.37
PLAU P00749 1/20 0.37
PLAT P00750 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
DHFR P00374 1/20 0.37
MAP4K4 O95819 1/20 0.37
DHODH Q02127 1/20 0.37
ERN1 O75460 1/20 0.36
AR P10275 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CTSD P07339 1/20 0.36
BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30125488 1.00 PDK2 (0.47) PDK2PTPRCPTPN1CHEK1ALOX5AP
SCHEMBL1812200 0.92 PDK2 (0.48) PDK2PTPRCPTPN1CHEK1ALOX5AP
SCHEMBL164197 0.89 EGFR (0.38) PDK2CHEK1MEN1POLBKMT2A
SCHEMBL1010811 0.89 EGFR (0.38) PDK2CHEK1MEN1POLBKMT2A
SCHEMBL9898302 0.89 HSP90AA1 (0.44) PDK2PTPRCPTPN1CHEK1ALOX5AP
SCHEMBL8511775 0.87 PDK2 (0.39) PDK2PTPRCPTPN1PGRNR3C1
SCHEMBL1815053 0.87 PDK2 (0.42) PDK2ALOX5APFEN1PGRAR
SCHEMBL30125362 0.86 PDK2 (0.40) PDK2PTPN1PGRARHSP90AA1
SCHEMBL165110 0.86 PDK2 (0.40) PDK2PTPN1PGRARHSP90AA1
SCHEMBL1012466 0.86 FYN (0.37) PDK2MAPK1KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313996-B1 INDENONAPHTHOPYRANS HAVING TRIALKYLSILYL AND ETHYLENICALLY UNSATURATED GROUPS TRANSITIONS OPTICAL LTD (IE) 2026-05-06 EP disclosed
US-20240376132-A1 Indenonaphthopyrans Having Trialkylsilyl and Ethylenically Unsaturated Groups TRANSITIONS OPTICAL, LTD. (IE) 2024-11-14 US disclosed
EP-4313996-A1 INDENONAPHTHOPYRANS HAVING TRIALKYLSILYL AND ETHYLENICALLY UNSATURATED GROUPS Transitions Optical, Ltd. (IE) 2024-02-07 EP disclosed
CN-117043168-A Indenonaphthopyrans having trialkylsilyl groups and ethylenically unsaturated groups 光学转变有限公司 2023-11-10 CN disclosed
US-9139552-B2 Indeno-fused naphthopyrans having ethylenically unsaturated groups TRANSITIONS OPTICAL, INC. (US) 2015-09-22 US disclosed
WO-2013090220-A1 INDENO-FUSED NAPHTHOPYRANS HAVING ETHYLENICALLY UNSATURATED GROUPS PPG INDUSTRIES, INC. (US) 2013-06-20 WO disclosed
US-20120132870-A1 Indeno-Fused Naphthopyrans Having Ethylenically Unsaturated Groups TRANSITIONS OPTICAL INC. (US) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376132-A1 Indenonaphthopyrans Having Trialkylsilyl and Ethylenically Unsaturated Groups B3GNT2, ERLIN1, RPN1 PDK2 1689/4885PTPRC 1170/4885PTPN1 1229/4885
US-20120132870-A1 Indeno-Fused Naphthopyrans Having Ethylenically Unsaturated Groups ACR, INTS6, B3GNT2 PDK2 2446/4885PTPRC 1216/4885PTPN1 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.